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Abstract 
 
Research suggests pre-pregnancy obesity is associated with an increased risk of 
macrosomia in the newborn. Since women are expected to gain weight during pregnancy, 
the standard recommendation of weight loss for obesity is not ideal for this population. In 
this systematic review of the literature regarding interventions for maternal obesity to 
reduce fetal macrosomia, 149 articles were screened using three different databases to 
identify recent randomized controlled trials related to this topic. A total of 11 full text 
articles were analyzed and included in the review. The articles addressed nutritional, 
lifestyle, and pharmacological interventions. The results indicated there is currently 
insufficient evidence to support specific treatment options for women with obesity during 
pregnancy to reduce the risk of fetal macrosomia.  
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Maternal Obesity and Fetal Macrosomia: An Integrative Review of the Literature 
Regarding Interventions 
Among the Healthy People 2020 objectives, in the section “Maternal, Infant and 
Child Health,” objective number 16.5 is to “Increase the proportion of women delivering 
a live birth who had a healthy weight prior to pregnancy” (HealthyPeople.gov Staff, 
2017, MICH-16.5). Recently, obesity is becoming a crucial topic among healthcare 
providers, due to its increasing prevalence and an increasing awareness of the negative 
health conditions with which it can be associated. Obesity in the pregnant mother requires 
specialized care based on the most current evidence, to best understand the many possible 
effects it could have on this unique state of health for the mother, as well as on the 
developing child. One important topic of researcher interest is the association between 
maternal pre-pregnancy obesity and macrosomia of the newborn.  
The World Health Organization [WHO] (2016) defined obesity as a body mass 
index of greater than or equal to 30 kg/m2. Bray (2018), in a literature review, identified 
numerous risk factors associated with obesity. He noted the development of weight gain 
tends to occur in relation to certain life circumstances, such as pregnancy and menopause 
in women and, in men, the transition from an active lifestyle in younger men to the more 
sedentary lifestyle typically seen in the 30s and older. He also indicated the mother’s 
nutritional status during pregnancy can affect the later metabolic profile of her offspring. 
He posited activity as a protective factor against obesity, and, in contrast, he maintained 
sitting and watching television for a long time is associated with an increased risk of 
obesity. Other behaviors which may lead to weight gain include not getting enough sleep,  
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quitting smoking, eating a lot of fat and sugar, binge-eating, and overeating, according to 
Bray. Weight gain can also be associated with taking certain medications, such as 
antidepressants and certain drugs for diabetes, Bray affirmed. He indicated obesity can 
also occur with certain diseases, such as Cushing’s syndrome or polycystic ovary 
syndrome, and other factors, such as genetics, environment, and psychological 
conditions. 
Obesity places a person at risk for many negative health conditions. Perreault 
(2018), in a literature review, indicated many studies have shown an increased risk of 
mortality in the obese population. Those with obesity are more likely to develop a 
chronic disease, such as diabetes, cancer, coronary heart disease, or depression, Perreault 
expressed. She noted there is evidence at least 11 different types of cancers may have 
links with obesity. She also mentioned obese men and women may face discrimination 
and stigma in society, and the financial cost of obesity is high, related to such factors as 
increased medical expenses and less productivity.  
Commonly used criteria for defining macrosomia include a fetal mass no less than 
4000 g or, alternatively, 4500 g (Gaudet, Ferraro, Wen, & Walker, 2014). Abramowicz 
and Anh (2018), in a literature review, identified risks macrosomia carries for both the 
mother and the fetus. Adverse maternal outcomes can include such things as postpartum 
hemorrhage, surgical delivery, or rupture of the uterus, they reported. They indicated the 
offspring may experience shoulder dystocia, low blood glucose levels at birth, obesity 
later in life, and more. If the infant’s birthweight is 5000 g or more, he is at increased risk 
of death, they warned. The issue is of special concern in certain impoverished nations,  
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since, according to Abramowicz and Ahn, mothers in these places may be at risk of 
pregnancy prior to full development of the pelvis or of having a small pelvis due to 
undernutrition. They may or may not have access to operative delivery if needed 
(Abramowicz & Ahn, 2018).  
Current literature provides evidence for the association between maternal obesity 
and macrosomia of the newborn. Abramowicz and Ahn (2018) declared obesity to be a 
significant risk factor for macrosomia, probably contributing to its development more 
often than diabetes. Similarly, in their systematic review and meta-analysis, Gaudet et al.  
(2014) identified strong support for the link between obesity and macrosomia in the 
research up to that time. Along the same lines, in a large study which included 276, 436 
births in 23 countries, Koyanagi et al. (2013) noted a significant connection between a 
high body mass index and macrosomia. Finally, Lutsiv, Mah, Beyene, and McDonald 
(2015) in a systematic review and meta-analysis found data to support the idea the risk of 
a large-for-gestational-age infant may be able to be stratified by increasing body mass 
index. If the evidence leans in support of an association between maternal body mass 
index and macrosomia, the next question is: What options do obese mothers have 
available to reduce their risk? While it is best for women to lose weight prior to becoming 
pregnant, due to safety concerns if weight is lost during gestation (Abramowicz & Ahn, 
2018), for some women, this weight loss is not accomplished. They enter pregnancy 
obese, and it is too late for prevention. A systematic review of literature regarding 
interventions to reduce the risk of fetal macrosomia in the offspring of obese pregnant  
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women may help to shed light on options available to these women for whom prevention 
is no longer a possibility.  
Method 
The researcher established certain criteria for studies to be included in this review. 
Sources had to be academic, randomized controlled trials, and published within the last 
five years (2013-2017), to promote the trustworthiness and relevance of the results. For 
simplification, the researcher assumed articles from PubMed were academic. She made 
one exception to the date range, identified later in the discussion of the search process. 
She defined the population as pregnant mothers with obesity, considered a body mass 
index of no less than 30 kg/m2 per the WHO guidelines (2016). Since the purpose of this 
review was to give a broad overview of interventions, she did not define characteristics of 
the mother such as ethnicity, age, comorbidities, and others. She researched the following 
outcome: reduction of risk of macrosomia of the infant. She included studies which used 
either 4000 g or 4500 g as the threshold of macrosomia (Gaudet et al., 2014). She only 
included articles in which interventions occurred after the woman was pregnant; she 
excluded trials with preventive measures as interventions. Studies had to compare the risk 
of macrosomia with the intervention to the risk with having no intervention, other than 
standard care.  
She discovered and obtained the majority of sources through searching three 
databases: CINAHL Plus with Full Text, Cochrane Library, and MEDLINE w/ Full-Text 
(EBSCO). She last searched these on February 2, 2018. In all three databases, she 
searched the terms “maternal obesity and macrosomia.” For CINAHL, she maintained the  
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default advanced search settings, with two alterations. (The default settings were as 
follows: “Search modes Boolean/Phrase;” no additional boxes checked or date range 
selected, and all drop-down list options set to “all.”) She set the “Published Date” to 
January 2013 to December 2017, and she checked the box to select only “Peer 
Reviewed” articles. For Cochrane, she used the default advanced search settings, except 
she limited the dates to 2013-2018. (The default settings were to search all years and 
Cochrane databases, with no other boxes checked.) After results were populated, she 
selected “Trials” instead of “Cochrane Reviews.” For MEDLINE, she kept all of the 
default advanced search settings, except changing the dates in the same manner as for 
CINAHL. (The default settings were as follows: “Search modes Boolean/Phrase;” no 
additional boxes checked or date range selected, and all drop-down list options set to 
“all.”) These databases provided the bulk of the sources for the review.  
She chose two other articles through using the Google search engine, on February 
6, 2018, using the search terms “maternal obesity and macrosomia interventions.” These 
appear in the reference list under Buschur and Kim (2012), which she accepted though 
slightly out of the date range, since it was still one of the first articles to be displayed on 
Google’s results, as well as Muktabhant, Lawrie, Lumbiganon, and Laopaiboon (2015). 
By using the “Similar Articles” feature of PubMed, where the former article was located, 
she identified one more article on the same date, Tanvig (2014). Also on February 6, she 
identified one other article; it was the original article (McCarthy, 2016) referenced in a 
response article (Ryu, Kim, Park, & Enkhbold, 2017) which had been populated in the  
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original search. It seemed more fitting to use the original document. After these articles 
were added, the searches were complete.  
 She screened all of the articles identified through searching for eligibility (n=202). 
She first removed all duplicates (n=53). If an article was clearly not relevant to the 
research question, based on the title, she removed it. If there was uncertainty, she 
screened the abstract for more information about the population and studied outcome, 
along with other inclusion criteria; if she found it to be unrelated, she removed it. This 
process eliminated many articles (n=120). The remaining articles either seemed likely to 
offer information which would help answer the research question, or they seemed 
unlikely to but were closely enough related they warranted further reading. Full text 
articles, if available, she screened for the remaining articles (n=29). Articles which did 
not meet the specified inclusion criteria she removed (n=18). There were a few articles 
which did not exactly meet the criteria but were closely related and had important 
information related to the research question. These she included in the review, to 
contribute to the overall perspective and increase the number of studies finally included 
in the review (n=11). The article screening process is depicted in Figure 2.  
 Results 
The researcher screened articles using the process described in the Prisma Flowchart 
(Moher, Liberati, Tezlaff, & Altman, 2009), seen in Figure 2. She included a total of 11 
articles in the review after screening. She documented reasons for excluding records 
which made it to the full text screening. Sixteen she excluded for not being randomized  
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     Figure 2 
Figure 2. PRISMA 2009 Flow Diagram. Adapted from Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses: The PRISMA Statement., by D. Moher, A. Liberati, J. Tezlaff, The PRISMA 
Group (2009). Retrieved March 6, 2018 from 
http://prismastatement.org/documents/PRISMA%202009%20flow%20diagram.pdf Copyright 
2009 by PRISMA. Adapted with permission.  
 
 
Records identified through 
database searching 
(n = 198 ) 
Additional records identified 
through other sources 
(n = 4 ) 
Records after duplicates removed 
(n =149) 
Full-text articles assessed 
for eligibility 
(n = 29 ) 
Full-text articles excluded, 
with reasons 
(n = 18 ) 
Studies included in 
qualitative synthesis 
(n = 11 ) 
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controlled trials (Ainscough, Lindsay, Gibney, & McAuliffe, 2016; Buschur  
& Kim, 2012; Catalano & deMouzon, 2015; Johansson et al., 2015; Lee, et al., 2016; 
Muktabhant et al., 2015; Opie, Neff, & Tierney, 2016; Poston & Patel, 2014; Robertson 
& Ladlow, 2017; Ryu et al., 2017; Sabau et al., 2014; Schuster, Madueke-Laveaux, 
Mackeen, Feng, & Paglia, 2016; Sukumar et al., 2016; Szostak-Wegierek, 2014; Tanvig, 
2014; Willis, Lieberman, & Sheiner, 2015). One article she excluded because it was the 
study design for a randomized controlled trial which had not yet been completed (Nagle 
et al., 2013). Another article she excluded because it was unable to be accessed using 
interlibrary loan (Bohiltea, Bodean, & Cîrstoiu, 2017). She attributed the large number of 
excluded articles, even prior to screening full texts, to the broad search terms used, 
compared to the specificity of the research question. Once the final articles had been 
selected, she reviewed them more thoroughly and assessed them for risk of bias.  
Reviews of Articles and Assessments of Risk of Bias 
Barakat and colleagues (2016) documented a randomized controlled trial which 
recruited pregnant women with uncomplicated pregnancies, who were Caucasian and 
spoke Spanish. After screening, randomization and attrition, their final analysis included 
382 women in the intervention group and 383 in the control group. The intervention 
consisted of tri-weekly, supervised, moderately difficult exercise sessions in a local 
hospital, during the time between the ninth to 11th week of pregnancy and the third 
trimester’s finish. In contrast, the control group women received advice to exercise and 
standard appointments but no extra interventions, besides calls to check on their  
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exercising status. Barakat and colleagues (2016) found the risk of macrosomia was 2.5 
times less in the intervention group for women of all body mass indexes [BMIs].  
 
Data Collection Form 
 
Article 
Name_________________________________________________________________________ 
Study 
design________________________________________________________________________ 
Level of 
evidence_______________________________________________________________________
_________________ 
Description of 
participants____________________________________________________________________ 
______________________________________________________________________________ 
Definition of Maternal 
Obesity_______________________________________________________________________ 
Definition of fetal 
macrosomia____________________________________________________________________
_______________________________ 
Intervention____________________________________________________________________
______________________________________________________________________________ 
General outcome concerning the research 
question:_______________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
Summary of significant 
limitations_____________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
Risk of 
bias___________________________________________________________________________
____________________________________________________________________________ 
Miscellaneous points of 
interest:________________________________________________________________________
______________________________________________________________________________
_________________________________________________________________________ 
 
               
Figure Two 
Figure 1. Data collection form. By C. Stalcup. Copyright 2018 by Charity Stalcup. Printed with permission.  
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             To contextualize the results of this study, the researcher assessed the risk of bias 
and found it to be average, on a subjective scale of low, average, and high. Barakat et al.  
(2016) specified a random numbers table was used to assign participants and conceal 
assignments, and three people accomplished the randomization. Barakat et al. indicated 
blinding of those performing the assessments but did not specify the methods of blinding. 
Since the intervention required participants to attend an exercise program, researchers 
could not blind the participants. The risk of attrition bias was unlikely as the researchers 
were unable to follow up with a similar number of women from the control group 
(37/420) and the intervention group (38/420), for similar reasons. Only two reasons were 
different between the groups. One was some of the intervention group were lost due to 
quitting the program and ruptured membranes. Another was some of the control group 
were lost due to persistent bleeding. Significantly, the researchers did not exclude anyone 
with a successful follow-up from the analysis, and the number lost to follow-up was 
within the expected percentage planned by Barakat and colleagues. Since Barakat et al. 
indicated they obtained secondary outcomes from the medical record, but did not specify 
what these outcomes were, selective outcome reporting may be a possibility. It is 
uncertain whether the researchers included all of the outcomes assessed in the report. 
Though there are strengths to this study, the uncertain aspects lend to a risk of bias rating 
of average. 
In a medication-intervention study, Chiswick et al. (2015) documented a 
randomized controlled trial which recruited Caucasian, pregnant women with a BMI of at 
least 30 kg/m2 in their 12th to 16th gestational week, who had a minimum age of 16 years.  
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They excluded women with complicated pregnancies, including diabetes or a history of 
gestational diabetes. The intervention was the administration of 500-2500mg of  
metformin per day, while the control group received a placebo. Chiswick et al. (2015) 
concluded metformin administration did not impact the baby’s birthweight. 
  With this study, there is an average risk of bias. Chiswick et al. (2015) reported 
the use of an electronic block randomization procedure to assign participants; however, 
they did not detail the procedure, other than how the data were stratified. They did not 
report any process of allocation concealment. While Chiswick et al. affirmed the blinding 
of all involved in the study, they did not elucidate, with the exception of the Data 
Monitoring Committee, whom the researchers did blind and instructed not to connect 
with participants. However, Chiswick et al. did not describe the process of ensuring 
members of the committee did not meet participants or share information with other 
members of the study. They described attrition thoroughly, including causes, such as 
withdrawal from the study, miscarriages, pregnancy terminations, inability to follow up, 
and stillbirths. Out of the original participants, they analyzed a total of  220/223 people 
for the control group and 214/226 for the intervention. Many who were analyzed did not 
continue in the study to the end of follow up (92 control, 82 intervention). For certain 
outcomes, Chiswick et al. only analyzed live births, and they used statistical methods to 
bring data to a normal distribution. Though the number of women analyzed was more 
than what the researchers expected to give 85% power to the study, the number who 
made it all the way through was lower. Selective outcome reporting seems unlikely due 
to the many outcomes Chiswick et al. reported, including ones that were not statistically  
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significant. The major risks of bias in this study seem to be in performance and detection, 
meaning those directing the intervention or assessing the outcomes may have been biased 
based on their knowledge of participant assignment (Cochrane Methods Bias Staff, 
2018), due to questions about blinding.  
Dodd et al. (2014) detailed a randomized controlled trial which recruited women 
from city hospitals in Australia who were pregnant with only one fetus in their 10th to 20th 
gestational week, were not type 1 or 2 diabetic, and had a BMI of at least 25 kg/m2. The 
intervention was nutrition, exercise, and lifestyle advice, along with accountability. In 
contrast, the control group received standard care, which was not likely to include this 
type of advice, based on the time and location of the study. Dodd et al. reported the 
intervention was associated with a decreased risk of fetal macrosomia but not the 
incidence of fetal large-for-gestational-age.  
Based on the strengths of this study by Dodd et al. (2014), the risk of bias is low. 
They accomplished the randomization by 1:1 ratio balanced variable blocks, and the 
researcher tasked with running the program was not involved in client interaction. Dodd 
et al. eluded to but did not detail the blinding of assessors. Dodd et al. did not blind 
participants or those involved in their care. They thoroughly documented attrition, and 
reasons for not completing the trial were similar and of similar numbers in both groups. 
The total number they analyzed were 1080 mothers and 1075 babies in the intervention 
group and 1072 mothers and 1067 babies in the control group, which met the sampling 
goals of the researchers. Selective outcome reporting is unlikely, as Dodd et al. reported 
many outcomes, including some which showed no statistical significance.  
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In another article, Donnelly, Walsh, Byrne, Molloy, & McAuliffe (2013) 
described a randomized controlled trial which was based on the recruitment of women  
who had one macrosomic baby, were pregnant again at less than 18 weeks gestation, 
were at least 18 years old, and had no comorbidities, including a history of gestational 
diabetes. A session of nutrition counseling about consuming a low-glycemic diet was the 
intervention. Donnelly et al. reported the intervention was associated with smaller infant 
thigh circumference, which may be linked to birthweight. Some other anthropometric 
measures were not significantly different between the groups, such as abdominal 
circumference and skin-fold thickness (Donnelly et al.). 
.   The risk of bias in this study is difficult to judge based on this article alone, as the 
methods of the trial are outlined in the original trial, so information from that trial is 
included in this assessment. The midwife researcher had the task of randomizing the 
mothers’ assignments, allocating them with a 1:1 ratio using a computer system and dark 
envelopes (Donnelly et al., 2013; Walsh, McGowan, Mahoney, Foley, & McAuliffe, 
2012). Donnelly et al. reported an adequate sample size of 265 infants. The original study 
thoroughly documented attrition and noted that it occurred similarly between the 
intervention and control groups (Walsh et al., 2012). Blinding of participants was not 
possible with the intervention, but the authors indicated at least the sonographers were 
blinded. It is unclear if anyone else was blinded (Walsh et al., 2012). Selective outcome 
reporting seems unlikely, since they reported several aspects of neonatal anthropometry, 
including some which did not show any significant difference between the two groups 
(Donnelly et al.). The overall risk of bias seems low.  
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Hayes, Bell, Robson, & Poston (2014) reported a randomized controlled trial 
which involved pregnant women with a BMI of at least 30 kg/m2. In this trial, the  
intervention addressed physical activity and nutrition. Hayes et al. reported an association 
between physical activity and a decreased risk of macrosomia of the infant.  
Rather than the article by Hayes et al. (2014), the risk of bias was assessed based 
on the original study (Poston et al., 2013) which Hayes et al. secondarily analyzed. 
Poston et al. accomplished randomization using an online program, but whether 
allocations were concealed from assessors was not specified. Poston et al. did not discuss 
blinding, and it would not have been possible given the nature of the intervention. The 
researchers depicted attrition clearly in a figure, with similarities between the control and 
intervention group and a final sample size of 75 and 84 mothers and babies, respectively, 
in the control group and 79 and 85 mothers and babies, respectively in the intervention 
group, all of whom were analyzed. The risk of selective outcome reporting seems low, 
since Poston et al. gave detailed reports of the outcomes and their significance and 
included the primary outcomes, even though they were not significant. With questions 
concerning blinding and concealment and a relatively small sample size but otherwise 
well documented methodology, the study by Poston et al. seems to have an average risk 
of bias.  
 In a secondary analysis, Horan, McGowan, Gibney, Donnelly, & McAuliffe 
(2014) reported outcomes of a randomized controlled trial which involved women 
pregnant with their second baby, whose first baby had been macrosomic. The 
intervention was advice about following a low-glycemic index diet, while the control  
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group did not receive dietary advice. Horan et al. reported the intervention did not lead to 
a significant effect on infant birthweight. Horan et al. specified that the statistical analysis  
was performed in two ways, one excluding and one including those who did not 
adequately report what they ate, but the difference was not significant. Most of the rest of 
the information related to risk of bias would be in the original study, which is the same 
one (Walsh et al., 2012) secondarily analyzed by Donnelly et al. (2014), therefore, this 
study can also be given a rating of low risk of bias.  
 Kizirian et al. (2016) described a randomized controlled trial which recruited 
women in Australia in their 12th – 20th gestational week with “ … the following risk 
factors: pregnancy BMI (in kg/m2) ≥ 30age ≥35 y, polycystic ovary syndrome, previous 
history of GDM or glucose intolerance, history of a previous newborn weighing >4000 g, 
family history of type 2 diabetes (first-degree relative), or belonging to an ethnic group 
with a high prevalence of GDM … ” and who did not have dietary restrictions or diabetes 
prior to pregnancy (Kizirian et al., 2016, p. 1074). The intervention was a low-glycemic 
diet, while the control group had a traditionally recommended high fiber diet. When 
factors such as weight the mother gained during pregnancy, BMI, and gestational 
diabetes were not accounted for, Kizirian et al. found an association between the low-
glycemic index diet and a decreased risk of macrosomia. When these factors were 
accounted for Kizirian et al. still found weight for age was higher in the control group.  
 Due to several shortcomings, the risk of bias in this study by Kizirian et al. (2016) 
is high. Kizirian et al. did not describe the process of randomization of participants and 
allocation concealment. There was no indication of blinding of those who analyzed the  
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data. The researchers and participants were not blinded. They documented attrition 
substantially. Forty-six of the participants of the original study were not willing to be a  
part of this follow up. Of those who were willing, some dropped out due to unstated 
personal factors or going out of the country. By the end of the 12-month study, the 
sample sizes were small at 15 infants in the intervention group and 14 in the control. 
Kizirian et al. also noted, due to the voluntary nature of participant selection from a 
previous study, many of the participants were well-educated women who may have had 
somewhat positive dietary practices in the first place. Since Kizirian et al. included 
several outcomes, including those which were not statistically significant or supportive of 
their hypothesis, selective outcome bias seems unlikely. The risk of bias in this study is 
somewhat high, but it is valuable as a pilot study and starting point for future randomized 
controlled trials. 
Syngelaki et al. (2016) reported a randomized controlled trial which recruited 
ethnically diverse, nondiabetic, singleton pregnant women, in their 12th to 18th 
gestational week, with a BMI greater than 35 and otherwise uncomplicated pregnancies, 
including no history of gestational diabetes. 1-3 g of metformin daily was the 
intervention, while control groups received a placebo medication. They provided exercise 
and nutritional advice to both groups. Syngelaki et al. indicated the intervention did not 
affect birthweight or size for age of the baby.  
 With its strengths and weaknesses, the risk of bias in this study by Syngelaki et al. 
(2016) is average. They accomplished randomization with numbers randomized by a 
computer, without restrictions, but did not specify the process of allocation concealment.  
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The pills of both the intervention and control group were the same in appearance, taste, 
and size, but Syngelaki et al. provided no other information about how they blinded  
participants, clinicians, and researchers. They provided attrition numbers, but not reasons 
for women declining to continue. They randomized 450 women, 202 in the intervention 
group and 198 in the control group. Selective outcome reporting seems unlikely, since 
Syngelaki et al. reported many outcomes, including non-significant findings.  
Along with these articles, McCarthy et al. reported another randomized controlled 
trial (2016). This trial recruited pregnant women who had not yet reached 20 weeks of 
gestation, spoke English, were not pregnant with multiples, did not have diabetes prior to 
pregnancy, had nothing known to be abnormal with the baby, and had a BMI of at least 
25 kg/m2. The intervention was “… serial self-weighing and simple dietary advice … ” 
(McCarthy et al., 2016, p. 966). McCarthy et al. did not find the intervention to be 
associated with a decrease in gestational weight gain or adverse outcomes such as 
shoulder dystocia or heavy perineal tearing. 
An average risk of bias seems appropriate for this trial completed by McCarthy et 
al. (2016). They accomplished randomization with a computerized random number table. 
They stratified by BMI and used a 1:1 ratio for allocation. With dark envelopes which 
were not opened until BMI was factored and informed consent to participate received, 
concealment was accomplished. Researchers did not blind participants and clinicians, but 
McCarthy et al. affirmed but did not detail blinding of assessors. They documented 
attrition well, with similar reasons for dropping out among both groups, such as giving 
birth elsewhere or miscarriage. They analyzed 184 women in the control group  
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and 187 in the intervention group. McCarthy et al. performed the analysis in two different 
ways, one including only those with all primary outcome data and one including those  
with some absent. The results were not significantly different. Selective reporting of 
outcomes may be present, as most of the outcomes focused on the mother. McCarthy et 
al. did not say much about fetal outcomes. Since most women in the control group also 
weighed themselves several times, McCarthy et al. noted more cross-over than expected 
between the groups.  
Zhang (2015) described a randomized controlled trial based in China which 
recruited women who had previously had one baby and had been healthy pre-gestation, 
were aged 18 to 40 years, and had given birth to a live baby. These women were tested 
for pregnancy regularly as part of the trial process. The intervention was the 
implementation of a nutritional regimen to give dietary council tailored to each individual 
early in pregnancy, and control group also participated. Zhang (2015) found the 
intervention to be effective in significantly lessening a woman’s risk of giving birth to a 
baby with macrosomia.  
Due to some considerable limitations, there is a high risk of bias with this study. 
Zhang (2015) indicated participant selection for the intervention group was random, but 
he did not specify methods. It is unclear whether the control group was random or if the 
researchers selected them based on similarities to the intervention group. Zhang gave no 
indication of allocation concealment or blinding of anyone involved, nor did he discuss 
attrition. It is possible Zhang did not include some outcomes, especially other pregnancy  
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complications, which might have been lumped into one category, such as “ … labor 
abnormalities … ” (Zhang, 2015, p. 647). 
In another article, Poston et al. (2015) reported a randomized controlled trial 
which involved women who were pregnant with one baby, in their 15th week to 19th week 
and 6th day of pregnancy, who had a BMI no less than 30 kg/m2, and no comorbidities or 
use of metformin. The intervention was an 8-week course of health coaching, regarding 
diet and exercise, while the control group simply attended their doctors’ appointments as 
usual. Poston et al. (2015) did not find an association between the intervention and a 
decreased risk of a large-for-gestational age infant.  
With its many strengths, the risk of bias with this study by Poston et al. (2015) is 
low. Poston et al. affirmed use of a computer system to randomize allocations, but details 
of how it functioned are not specified, except minimization was used based on specific 
factors listed in the article. Researchers and participants were unblinded, apparently 
including those who analyzed the data. Poston et al. detailed attrition, including 
participants’ reasons for leaving the trial, which were the same in both groups, including 
such things as fetal death and failure to attend appointment. Poston et al. documented the 
exclusion of fetal deaths in both groups. The control sample size was 651 mothers and 
751 neonates; there were 629 mothers and 761 neonates in the intervention group. The 
risk of selective outcome reporting is low because Poston et al. included many outcomes 
in the text and even more in supplementary tables, including insignificant findings. 
Integrated Results of All Studies Included in Review 
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One of the biggest areas of possible bias which the researcher noticed across the 
studies is not blinding participants and researchers. Donnelly and colleagues (2013) as 
well as Walsh et al. (2012) pointed out blinding is not an option for nutritional 
interventions. This point could also be applied to exercise interventions. In either case, it  
is necessary for the participant and at least some of the researchers to know what group 
they are in. Risk of bias by article is included in Table 1.                            
For most of the articles, exclusion criteria included those who had certain 
complications of pregnancy, sometimes including gestational diabetes or a history of it 
(Barakat et al., 2016; Chiswick et al., 2015; Dodd et al., 2014; Donnelly et al., 2013; 
Horan et al., 2014; Kizirian et al., 2016; McCarthy et al., 2016; Poston et al., 2015; 
Syngelaki, 2016; Zhang, 2015). Obviously, safety was the priority with these studies, but 
it does limit the generalizability of the findings. It is difficult to say whether the outcomes 
would be the same if women with complicated pregnancies were included in the 
sampling. Women with other pregnancy complications besides obesity cannot necessarily 
have the results applied to their situations. There is a lack of research involving treatment 
in this vulnerable population and what treatments may be effective and safe for them. The 
limited studies of complicated pregnancies form an obstacle to evidence-based care for 
women in this category.  
Of the 11 articles screened, seven were carried out in Europe, (Barakat et al., 
2016; Chiswick et al., 2015; Donnelly, 2013; Hayes, 2014; Horan et al., 2014; Poston et 
al., 2015; Syngelaki et al., 2016), three in Australia or New Zealand (Dodd 2014; 
Kizirian et al., 2016; McCarthy et al., 2016), and one in China (Zhang, 2015). Research is  
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lacking for the Americas, Africa, and Asia. It is uncertain whether the results of these 
studies are generalizable to these other continents, as socioeconomics and ethnicity are 
important factors in the etiology of obesity (Bray, 2018). Some of the studies required 
participants to have an ability to speak English (Horan et al., 2014; McCarthy, 2016).  
Four of the studies assessed an ethnically diverse population (Dodd, 2014; Kizirian et al., 
2016; Poston et al., 2015; Syngelaki et al., 2016), but three of the studies recruited 
primarily Caucasians (Barakat et al., 2016; Chiswick et al., 2015; Horan et al., 2014).  
Table 1 
Summary of Findings 
Trial (By Citation) Intervention Type Outcome Risk of Bias  
Chiswick et al. 2015 Medication No impact on 
birthweight  
Average 
Donnelly et al. 2015 Nutritional Decreased infant 
thigh circumference 
Low 
Kizirian et al. 2016 Nutritional Decreased risk large 
weight for age  
High  
Syngelaki et al. 
2016 
Medication No effect on 
birthweight 
Average  
Barakat et al. 2016 Exercise Decreased risk of 
macrosomia 
Average  
Dodd et al. 2014 Nutritional and 
Exercise 
Decreased risk of 
macrosomia 
Low  
Hayes et al. 2014 Exercise Decreased risk of 
macrosomia 
Average 
Horan et al. 2014 Nutritional No effect on 
birthweight 
Low 
Poston et al. 2015 Nutritional and 
Exercise 
No effect on LGA  Low  
Zhang 2015 Nutritional  Decreased risk 
macrosomia 
High  
McCarthy et al. 
2016 
Behavioral and 
Nutritional 
Did not lead to 
decreased 
gestational weight 
gain, negative 
outcomes 
Average  
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Whether the results of these ethnically limited studies are generalizable to other 
populations is questionable.    
Studies such as those reviewed here involving asking women to agree to an 
intervention must necessarily have informed consent; women cannot be forced to 
participate in a trial. Hayes et al. (2014) noted evidence for the benefit of exercise to 
obese pregnant women has not helped to increase their level of activity, so education is 
not necessarily a sufficient intervention. For some, this lack of response is due to 
logistical issues or discomfort with activity (Hayes et al., 2014). Poston et al. (2015) 
pointed out there is difficulty in recruiting obese pregnant women for behaviorally-based 
interventions, and effectiveness of the interventions may only be generalizable to 
motivated women. Kizirian et al. (2016) noted women who participated in their trial 
tended to be well educated and already had some beneficial dietary practices prior to the 
intervention. It is difficult to know if effectiveness of interventions can be generalized to 
those who did not make the choice to participate in the studies.  
Five of the trials reviewed utilized a behavioral intervention (Barakat et al., 2016; 
Dodd et al., 2014; Hayes et al., 2014; Poston et al., 2015; McCarthy et al., 2016). Hayes 
et al. (2014) had women wear a device to objectively measure level of activity. Barakat et 
al. (2016) designed an in-hospital regular exercise program involving various forms of 
moderately difficult exercise. Poston et al. (2015) used an eight-week program of in 
person and over the phone sessions, essentially providing coaching for women about 
behaviors and how to set goals and increase activity level from what they are normally 
used to. McCarthy et al. (2016) used serial self-weighing as a behavioral intervention,  
MATERNAL OBESITY AND MACROSOMIA 26 
 
focusing on its low cost and low difficulty as an intervention. Dodd et al. (2014) used an 
intervention which focused on providing accountability and encouraging individualized 
goal setting to help women increase their activity levels. Hayes et al. (2014) emphasize 
the importance of behavioral interventions which are acceptable to the women 
participating in them for best outcomes. The results of these behavioral interventions  
varied, with three reports of reduced risk of macrosomia (Barakat et al., 2016; Dodd et 
al., 2014; Hayes et al., 2014) and two reports of insignificant outcomes (McCarthy et al., 
2016; Poston et al., 2015). Research is still lacking in trials comparing different styles of 
behavioral intervention, to see which is most effective at producing change in women’s 
lifestyles.  
Eight of the trials consisted of a dietary intervention (Dodd et al., 2014; Donnelly 
et al., 2015; Horan et al., 2014; Kizirian et al., 2016; McCarthy et al., 2016; Poston et al., 
2015; Zhang, 2015). Donnelly et al. (2013) and Kizirian et al. (2016) advised a low-
glycemic index diet, while Poston et al. (2015) advised a medium-to-high-glycemic index 
diet. Zhang (2015) focused on general good nutrition habits, with more specific advice 
for those with gestational diabetes. Dodd et al. (2014) gave individualized dietary advice 
and addressed things like sugar and fat content of diet. As with the behavioral 
interventions, the results of these trials varied, with four reports of decreased risk of 
macrosomia or a related outcome (Dodd et al., 2014; Donnelly et al., 2015; Kizirian et 
al., 2016; Zhang, 2015) and three reports of no significant effect on macrosomia or an 
alternately chosen, similar outcome (Horan et al., 2014; McCarthy et al., 2016; Poston et  
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al., 2015). Randomized controlled trials are lacking about specific foods which may be 
beneficial or add risk to the pregnant woman and her baby.  
Chiswick et al. (2015) and Syngelaki et al. (2016) studied metformin 
administration as an intervention. Syngelaki et al. used a maximum dose higher than the 
dose Chiswick et al. administered (2500 and 3000 mg, respectively). Syngelaki et al. also 
implemented dietary and exercise counseling, to both the intervention and the control  
groups. Both trials excluded women with complicated pregnancies or comorbidities 
(Chiswick et al.; Syngelaki et al.). Neither Chiswick et al. or Syngelaki et al. found 
metformin to be useful in reducing the risk of macrosomia. Research is lacking 
concerning whether metformin may be useful in women with high risk pregnancies. 
Randomized controlled trials of other drugs which may be effective in reducing risk of 
macrosomia are lacking.  
Of the 11 studies included, four had outcomes of a decreased risk of macrosomia 
in the intervention. The interventions included behavioral counseling, exercise, and 
nutritional guidance (Barakat et al., 2016; Dodd et al., 2014; Hayes, 2014; Zhang, 2015). 
Poston et al. (2015) performed a well-designed study with large sample sizes and found 
no significant effect of a behavioral and nutritional program in reducing the risk of 
macrosomia. They postulated past reviews which found an association between 
behavioral changes and reduced risk of macrosomia were based on small or limited 
studies and therefore biased. Bias may indeed be an issue but is questionable. The sample 
sizes of the articles should be considered when assessing bias. Hayes et al. (2014) had a 
small sample size of only 183, while Barakat et al. (2016) had a sample size of 765.  
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Zhang (2015) had a relatively small sample size of 256 and a high risk of methodological 
bias. Dodd et al. (2014) had a large sample size of 2152 mothers and 2142 infants, which 
is actually more than the sample size of Poston et al. (2015), who had a sample size of 
1555. It is unclear what caused the difference in outcome between the two large trials, but 
the sample size and design of both seem credible and the findings valid (Dodd et al., 
2014; Poston et al., 2015).  
               The outcomes of studies which did not find a decreased risk of macrosomia 
varied. The two trials which used metformin as an intervention showed no effect on 
macrosomia, but they did find some other possible benefits, such as a decreased risk of 
inflammatory biomarkers and preeclampsia and lower gestational weight gain in the 
mother (Chiswick, 2015; Syngelaki, 2016). Donnelly et al. (2013) found their dietary 
intervention to be associated with a smaller thigh circumference in the infant, but they did 
not find this association with other measures of infant anthropometry such as abdominal 
circumference or skin-folds. Kizirian et al. (2016) found a relationship between a low 
glycemic index diet and lower infant bodyweight, but the significance of this relationship 
was lost when outlying infants were included in the analysis and when adjustments were 
made for maternal characteristics such as BMI. Even with the adjustments and inclusion 
of the outliers, Kizirian et al. (2016) still found an association between the intervention 
and lower weight for age of the baby. Horan et al. (2014) found an association between 
the intervention group and lower levels of central adiposity among the neonates. 
McCarthy et al. (2016) did not find their intervention to effectively reduce poor maternal 
outcomes or gestational weight gain, but they did find self-weighing had no association  
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with poor quality of life in those studied. Each study offered valuable information to be 
used for further research.  
Discussion 
 The results of this literature review were inconclusive to define a specific, reliable 
intervention for preventing macrosomia in women who are currently pregnant and obese. 
There is evidence exercise, nutrition, and lifestyle coaching may reduce the risk of infant  
macrosomia, large for gestational age, or increased thigh circumference (Barakat et al., 
2016; Dodd et al., 2014; Donnelly et al., 2015; Hayes et al., 2014; Kizirian et al., 2016), 
but other studies, including a well-constructed study with a strong intervention and low 
risk of bias, found no effect on large-for-gestational age of the fetus and macrosomia 
(Horan et al., 2014; Poston et al., 2015). In addition, a low cost, simple intervention was 
not found to be helpful in improving maternal outcomes (McCarthy et al., 2016). None of 
the results of these studies can simply be ignored. More research with strong 
methodologies, large sample sizes, and varied populations is needed to identify effective, 
reliable interventions for these women and their offspring.  
 This review has many limitations. One researcher screened and reviewed articles. 
The researcher had to make certain simplifications in order to keep the review 
manageable, given the time and resources available. These simplifications included 
things such as only using one set of search terms, limiting to randomized controlled trials, 
and focusing only on main outcomes of each article which related to the research 
question. If an article’s relevance to the review was questionable, and it was not readily 
available, the tendency was to screen it out. Specifically, one article which otherwise  
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seemed to meet the criteria to be included, she left out due to inaccessibility (Bohiltea et 
al., 2017). She included articles which did not directly answer the research question. She 
accomplished data extraction from the selected articles and synthesis of the data primarily 
in a non-systematic, qualitative manner. Bias assessment was subjective and the opinion 
of only one researcher. The researcher was a senior level, Bachelor’s of Science in 
Nursing student and had only limited knowledge in the field of the research question.  
The importance of research on the topic of maternal obesity and its relationship to 
macrosomia as well other negative health outcomes cannot be overstated. In Committee 
Opinion No. 549, the American College of Obstetricians and Gynecologists (2013), in the 
abstract, stated, “In the United States, more than one third of women are obese, more than 
one half of pregnant women are overweight or obese, and 8% of reproductive-aged 
women are extremely obese, putting them at a greater risk of pregnancy complications” 
(p. 213). Obesity is an issue that affects the sisters, daughters, mothers, and friends, of a 
huge percent of America’s population. The ethical principles of beneficence and 
nonmaleficence dictate doing what is possible to give these women options for 
intervention.  
To effectively prevent macrosomia in obese mothers, interdisciplinary 
collaboration is essential to ensure all aspects of the issue are addressed. This principle 
can be seen in that a search of this topic populated articles from many different journals 
and medical specialties, from obesity to endocrinology to obstetrics. Bogaerts, Van den 
Bergh, Witters, and Devlieger (2013) found maternal anxiety experienced early on in 
pregnancies of obese women may be linked to postpartum weight retention. If the woman  
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is anxious due to the obstetric risk factors she has due to her obesity, she may find herself 
locked in an unfortunate cycle, anxious in relation to obesity and obese in relation to 
anxiety. Pregnant women may have various reasons for not seeking medical help with 
weight management, such as logistics, work responsibilities, feeling less up to being out 
and about during pregnancy, or simply insufficient motivation (Olander & Atkinson,  
2013). There are numerous factors to consider when seeking to effectively address this 
important issue.  
In treating women with obesity, practitioners need to consider the psychological, 
psychosocial, and physical aspects of the woman’s condition. Does she desire to lose 
weight? If so, what circumstances are preventing her from accomplishing this goal? Does 
she need more education regarding her risk or more motivation to do something about the 
knowledge she already has? Would she benefit from a social worker consultation, to help 
address life circumstances that may be involved? The fact that research regarding 
interventions for maternal obesity in the pregnant mother is sparse reinforces the 
importance of preventative care. Still, even the limited research available may be useful 
to provide encouragement and motivation for a pregnant mother with obesity, and some, 
such as the very noninvasive intervention in the McCarthy et al. (2016) study could likely 
be trialed safely under a doctor’s supervision. It is the responsibility of both the patient 
and the practitioner to become informed and address this issue.  
For the Christian practitioner, this issue is of special significance. Psalms 139:2-3 
states:  
MATERNAL OBESITY AND MACROSOMIA 32 
 
For you formed my inward parts; you knitted me together in my mother’s womb. 
I praise you, for I am fearfully and wonderfully made. … Your eyes saw my 
unformed substance; in your book were written, every one of them, the days that 
were formed for me, when as yet there was none of them. (English Standard 
Version) 
 
            God knows and cares deeply about the life of both the mother with obesity and 
the life of her unborn child. Christian practitioners have a responsibility to follow God’s 
example by caring for and valuing these mothers and their babies. By offering 
interventions to these women to reduce their pregnancy risks, they can offer hope. This 
hope is especially important in a population of women at risk of depression and public 
stigma related to their weight (Perreault, 2018). By researching effective treatments and 
applying these in practice, these practitioners can show they value both mother and child 
in the way God intended.  
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